LifeSci Acquisition Corp. (LSAC) to Combine with Vincera Pharma, Inc.

LifeSci Acquisition Corp. (LSAC), announced this morning that they have entered into a definitive business combination agreement with Vincera Pharma, Inc. (“Vincera”), a clinical-stage biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics. LifeSci IPO’d earlier this year as Covid-19 was dominating the headlines and grinding global commerce
Read More